These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3741541)

  • 1. Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988.
    Imura Y; Terashita Z; Nishikawa K
    Life Sci; 1986 Jul; 39(2):111-7. PubMed ID: 3741541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).
    Imanishi N; Komuro Y; Morooka S
    Lipids; 1991 Dec; 26(12):1391-5. PubMed ID: 1819739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
    Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
    Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor.
    Choi IH; Ha TY; Lee DG; Park JS; Lee JH; Park YM; Lee HK
    Clin Exp Immunol; 1995 Jun; 100(3):390-4. PubMed ID: 7774047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
    Ono S; Mochizuki H; Tamakuma S
    Am J Surg; 1996 Apr; 171(4):409-15. PubMed ID: 8604832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of SM-12502 on disseminated intravascular coagulation (DIC) in tumor-bearing rats.
    Morooka S; Natsume Y
    Adv Exp Med Biol; 1996; 416():189-93. PubMed ID: 9131147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC.
    Ono S; Tamakuma S; Mochizuki H; Kinoshita M; Ohkusa Y; Aosasa S; Oda Y; Ohe H
    Surg Today; 1993; 23(3):228-33. PubMed ID: 8467174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of activated platelets in endotoxin-induced DIC in rats.
    Ito T; Asai F; Oshima T; Kobayashi S
    Thromb Res; 1990 Aug; 59(4):735-47. PubMed ID: 2080492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is platelet activating factor (PAF) a mediator of endotoxin shock?
    Terashita Z; Imura Y; Nishikawa K; Sumida S
    Eur J Pharmacol; 1985 Feb; 109(2):257-61. PubMed ID: 3996473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure.
    Ou MC; Kambayashi J; Kawasaki T; Uemura Y; Shinozaki K; Shiba E; Sakon M; Yukawa M; Mori T
    Thromb Res; 1994 Feb; 73(3-4):227-38. PubMed ID: 8191415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental model of disseminated intravascular coagulation induced by sustained infusion of endotoxin.
    Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
    Res Exp Med (Berl); 1981; 179(3):223-8. PubMed ID: 7323452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats.
    Albert DH; Luo G; Magoc TJ; Tapang P; Holms JH; Davidsen SK; Summers JB; Carter GW
    Shock; 1996 Aug; 6(2):112-7. PubMed ID: 8856845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation.
    Yokota Y; Inamura N; Asano M; Yamamoto Y; Nakahara K; Notsu Y; Ono T; Watanabe M
    Eur J Pharmacol; 1994 Jun; 258(3):239-46. PubMed ID: 8088357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats.
    Inoue Y; Kohno S; Miyazaki T; Yamaguchi K
    Tohoku J Exp Med; 1991 Mar; 163(3):175-85. PubMed ID: 2063402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kondo M
    Thromb Haemost; 1983 Jun; 49(3):190-2. PubMed ID: 6879507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CV-3988 - a specific antagonist of platelet activating factor (PAF).
    Terashita Z; Tsushima S; Yoshioka Y; Nomura H; Inada Y; Nishikawa K
    Life Sci; 1983 Apr; 32(17):1975-82. PubMed ID: 6403793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Furukawa Y; Murakami M; Watanabe K; Kondo M
    Thromb Haemost; 1982 Oct; 48(2):235-7. PubMed ID: 7179203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of superoxide dismutase and catalase on disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Yoshida N; Seto O; Kondo M
    Thromb Haemost; 1983 Dec; 50(4):869-72. PubMed ID: 6665768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.